Ann (Aine) Hanly, Ph.D.

Ann (Aine) Hanly, Ph.D.

Executive Vice President and Chief Technology OfficeratVir Biotechnology· In proxies 2021–2024

Pay in FY2024-55% from the year before · Vir Biotechnology stock -27.0% the same year

Ann (Aine) Hanly, Ph.D. was paid $1.4M in FY2024 (Dec), down 55%. Vir Biotechnology stock fell 27.0% that year.

Pay$100 in the stock at the end of FY20 → $27
Pay is from the Summary Compensation Table of each Vir Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vir BiotechnologyPublic company · 5 yr
    • Executive Vice President and Chief Technology Officer2021 – Present · 5 yrStock in role -60%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?